Cargando…
Production and Evaluation of an Avian IgY Immunotoxin against CD133+ for Treatment of Carcinogenic Stem Cells in Malignant Glioma: IgY Immunotoxin for the Treatment of Glioblastoma
BACKGROUND: Glioblastoma is the most common malignant tumor of Central Nervous System. Despite the research in therapeutics, the prognosis is dismal. Malignant glioma stem cells (MGSCs) are a major cause of treatment failure and increasing tumor recurrence. In general, cancer stem cells (CSCs) expre...
Autores principales: | Chavez-Cortez, Elda-Georgina, Vargas Felix, Gustavo, Rangel López, Edgar, Sotelo, Julio, Martínez-Canseco, Carlos, Pérez-de la Cruz, Verónica, Pineda, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582814/ https://www.ncbi.nlm.nih.gov/pubmed/31275378 http://dx.doi.org/10.1155/2019/2563092 |
Ejemplares similares
-
IgY Antibodies as Biotherapeutics in Biomedicine
por: León-Núñez, Diana, et al.
Publicado: (2022) -
IgY‐binding peptide screened from a random peptide library as a ligand for IgY purification
por: Khan, Kamrul Hasan, et al.
Publicado: (2017) -
Avian IgY antibodies and their recombinant equivalents in research, diagnostics and therapy
por: Spillner, Edzard, et al.
Publicado: (2012) -
Trends in industrialization and commercialization of IgY technology
por: Yakhkeshi, Saeed, et al.
Publicado: (2022) -
Avian antibodies (IgY) against Trypanosoma cruzi: Purification and characterization studies
por: Grando, Thirssa H., et al.
Publicado: (2017)